Literature DB >> 28848290

Prevalence of Pneumocystis jirovecii among immunocompromised patients in hospitals of Tehran city, Iran.

Mohammad Mohsen Homayouni1, Hamed Behniafar2, Amir Sayed Ali Mehbod1, Mohammad-Javad Mohammad-Sadeghi1, Bahman Maleki3.   

Abstract

Pneumocystis jirovecii is an opportunistic organism that can cause extreme complications such as Pneumocystis pneumonia in immunocompromised individuals. There is no comprehensive study was conducted Iran to determine the prevalence of this infection in susceptible individuals. In the present study, 160 sera samples were collected from immunocompromised patients, including acquired immunodeficiency syndrome (AIDS) patients, diabetic patients, Hodgkin lymphoma patients and non-Hodgkin lymphoma patients. The specimens were collected from Imam Khomeini and army's 501 hospitals. The specimens were examined using indirect fluorescent antibody test. The results of the study showed that 39.30% specimens were found positive, with different rates in different groups, including 20, 22.50, 37.50, and 77.50% of diabetic patients, non-Hodgkin patients, Hodgkin lymphoma patients, and AIDS patients, respectively. This occurrence is relatively high and can be a potential life-threatening hazard to infected patients in studied groups, on the other hand the organism can be transmitted from infected people to other susceptible individuals.

Entities:  

Keywords:  IFA; Immunocompromised individuals; Pneumocystis jirovecii; Tehran

Year:  2017        PMID: 28848290      PMCID: PMC5555945          DOI: 10.1007/s12639-017-0901-y

Source DB:  PubMed          Journal:  J Parasit Dis        ISSN: 0971-7196


  23 in total

1.  ENDEMIC PNEUMOCYSTIS CARINII PNEUMONIA IN SOUTH IRAN.

Authors:  C POST; W DUTZ; I NASARIAN
Journal:  Arch Dis Child       Date:  1964-02       Impact factor: 3.791

2.  A stain for fungi in tissue sections and smears using Gomori's methenamine-silver nitrate technic.

Authors:  R G GROCOTT
Journal:  Am J Clin Pathol       Date:  1955-08       Impact factor: 2.493

3.  Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates.

Authors:  Élie Azoulay; Anne Bergeron; Sylvie Chevret; Nicolas Bele; Benoît Schlemmer; Jean Menotti
Journal:  Chest       Date:  2009-03       Impact factor: 9.410

4.  Evaluation of diagnostic value and epidemiological implications of PCR for Pneumocystis carinii in different immunosuppressed and immunocompetent patient groups.

Authors:  A Sing; K Trebesius; A Roggenkamp; H Rüssmann; K Tybus; F Pfaff; J R Bogner; C Emminger; J Heesemann
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

5.  The use of mucolysed induced sputum for the identification of pulmonary pathogens associated with human immunodeficiency virus infection.

Authors:  V L Ng; I Gartner; L A Weymouth; C D Goodman; P C Hopewell; W K Hadley
Journal:  Arch Pathol Lab Med       Date:  1989-05       Impact factor: 5.534

6.  Evaluation of an indirect fluorescent-antibody stain for detection of Pneumocystis carinii in respiratory specimens.

Authors:  V L Ng; D M Yajko; L W McPhaul; I Gartner; B Byford; C D Goodman; P S Nassos; C A Sanders; E L Howes; G Leoung
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

7.  Risk of Pneumocystis jiroveci pneumonia in patients long after renal transplantation.

Authors:  Geertrude H Struijk; Anton F Gijsen; Si La Yong; Aeilko H Zwinderman; Suzanne E Geerlings; Kamilla D Lettinga; Karlijn A M I van Donselaar-van der Pant; Ineke J M ten Berge; Frederike J Bemelman
Journal:  Nephrol Dial Transplant       Date:  2011-03-08       Impact factor: 5.992

8.  Pneumocystis jiroveci genotypes in the Spanish population.

Authors:  M A Montes-Cano; C de la Horra; J Martin-Juan; J M Varela; R Torronteras; N Respaldiza; F J Medrano; E J Calderón
Journal:  Clin Infect Dis       Date:  2004-06-14       Impact factor: 9.079

9.  Development of a loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia.

Authors:  Natsu Uemura; Koichi Makimura; Masanobu Onozaki; Yoshihito Otsuka; Yasuhiro Shibuya; Hirohisa Yazaki; Yoshimi Kikuchi; Shigeru Abe; Shoji Kudoh
Journal:  J Med Microbiol       Date:  2008-01       Impact factor: 2.472

10.  Prospective evaluation of a monoclonal antibody in diagnosis of Pneumocystis carinii pneumonia.

Authors:  J A Kovacs; V Gill; J C Swan; F Ognibene; J Shelhamer; J E Parrillo; H Masur
Journal:  Lancet       Date:  1986-07-05       Impact factor: 79.321

View more
  4 in total

Review 1.  Update on invasive fungal infections in the Middle Eastern and North African region.

Authors:  Marwan Osman; Aisha Al Bikai; Rayane Rafei; Hassan Mallat; Fouad Dabboussi; Monzer Hamze
Journal:  Braz J Microbiol       Date:  2020-07-05       Impact factor: 2.476

2.  A multi-centered study of Pneumocystis jirovecii colonization in patients with respiratory disorders: Is there a colonization trend in the elderly?

Authors:  Mahdi Abastabar; Elham Mosayebi; Tahereh Shokohi; Mohammad T Hedayati; Mohammad R Jabari Amiri; Zahra Seifi; Iman Haghani; Masoud Aliyali; Sassan Saber; Maryam-Fatemeh Sheikholeslami
Journal:  Curr Med Mycol       Date:  2019-09

3.  Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples.

Authors:  A Kilic; S Elliott; L Hester; E Palavecino
Journal:  J Mycol Med       Date:  2020-01-31       Impact factor: 2.391

4.  Pneumocystis jirovecii Pneumonia and Human Immunodeficiency Virus Co-Infection in Western Iran.

Authors:  Arezoo Bozorgomid; Yazdan Hamzavi; Sahar Heidari Khayat; Behzad Mahdavian; Homayoon Bashiri
Journal:  Iran J Public Health       Date:  2019-11       Impact factor: 1.429

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.